Accession Number: | 0001567619-21-005770 |
Date: | 2021-03-03 |
Issuer: | IRONWOOD PHARMACEUTICALS INC (IRWD) |
Original Submission Date: |
DENNER ALEXANDER J
C/O IRONWOOD PHARMACEUTICALS, INC.
100 SUMMER STREET, SUITE 2300
BOSTON, MA 02110
SARISSA CAPITAL MANAGEMENT LP
660 STEAMBOAT ROAD
3RD FLOOR
GREENWICH, CT 06830
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
CLASS A COMMON STOCK | 2021-03-03 | P | 350,000 | a | $10.02 | 15,740,000 | indirect | f2 | |
CLASS A COMMON STOCK | 2021-03-04 | P | 250,000 | a | $10.00 | 15,990,000 | indirect | f2 | |
CLASS A COMMON STOCK | 2021-03-05 | P | 175,000 | a | $10.01 | 16,165,000 | indirect | f2 | |
CLASS A COMMON STOCK | 2021-03-03 | 0 | $0.00 | 37,844 f1 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | shares held directly by dr. denner. |
f2 | consists of shares that are held by sarissa capital management lp ("sarissa capital") or by the funds and other investment vehicles (the "sarissa funds") for which sarissa capital serves as investment advisor. dr. denner is the chief investment officer of sarissa capital and the managing member, general partner or other control party of the sarissa funds. by virtue of the foregoing, dr. denner may be deemed to indirectly beneficially own the shares that these funds directly beneficially own. each of sarissa capital, the sarissa funds and dr. denner disclaims beneficial ownership of these shares except, in each case, to the extent of their pecuniary interest therein. |